A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
Launched by NYU LANGONE HEALTH · Apr 28, 2021
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping parents take care of their children with complex medical needs after they leave the hospital. Children with medical complexity often have multiple ongoing health issues that make it challenging for them to recover at home. The goal of the study is to find ways to make the transition from hospital to home smoother and to reduce the chances of health problems that could lead to another hospital visit.
To join the study, parents or legal guardians must speak English or Spanish and be the primary caregivers of a child under 18 who has significant health issues affecting two or more body systems or who relies on medical technology like feeding tubes or breathing equipment. Participants will be asked to take part in different study activities and may be randomly assigned to a group that receives specific support. The trial is currently recruiting participants, so this is a great opportunity for families looking for additional help during their child's recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parents
- • English or Spanish-speaking
- • Parent or legal guardian and primary caregiver of child who has medical complexity (defined by significant chronic conditions in ≥2 body systems, progressive conditions associated with decreased life expectancy, dependence on technology for \>6 months \[e.g., respiratory equipment, central lines, feeding tubes\], or progressive/metastatic malignancies) who was admitted to the acute or intensive care units
- • The individual's child is ≤18 years old
- • The individual's child was discharged home or is expected be discharged home on ≥1 daily medication.
- • Willingness to be randomized to intervention group
- • Willingness and ability to participate in study procedures
- Exclusion Criteria:
- • Parents
- • Caregiver \<18 years old
- • Poor visual acuity (\<20/50 corrected on Rosenbaum screener for in-person recruitment; by subject report for phone recruitment)
- • Self-reported hearing difficulty
- • Previously enrolled.
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Alexander F Glick, MD, MS
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials